JAK2 and colorectal carcinoma: In vitro experiments showed that Convastatin (0–100 nM) significantly downregulated STAT3 phosphorylation levels by inhibiting the interaction of JAK2/STAT3 and mTOR/STAT3 signaling pathways, thereby inhibiting the proliferation, migration and invasion of CRC cells and inducing apoptosis.